GlassScriptPhysician profile
Amanda D Strathmann
NPI 1144702945
$2,129.78
in general payments reported to CMS, 2019-2025
17 companies · $1,774 in 2025
The $1,774 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $14.20 · 2023: $15.23 · 2024: $144 · 2025: $1,774.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,030 · Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,029.89 |
| Food and Beverage | $903.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,327.49 | 2025 | Evenity |
| Takeda Pharmaceuticals U.S.A., INC. | $121.31 | 2021-2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $116.02 | 2021 | |
| Vanda Pharmaceuticals INC. | $102.03 | 2025 | Fanapt |
| Lilly USA, LLC | $65.51 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Pfizer INC. | $63.28 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $60.23 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $44.76 | 2021-2024 | Shingrix, Arexvy |
| Novo Nordisk INC | $41.60 | 2025 | Wegovy |
| Abbvie INC. | $41.52 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $31.03 | 2024-2025 | Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.84 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $25.71 | 2025 | Auvelity |
| Lundbeck LLC | $23.39 | 2025 | Rexulti |
| Inspire Medical Systems, INC. | $17.86 | 2025 | Inspire |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.70 | 2025 | Cologuard Collection Kit |
| Corium, LLC | $8.50 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Strathmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.